Bleeding Symptoms of Carriers of Hemophilia A and B
This study has been completed.
Sponsor:
Sahlgrenska University Hospital, Sweden
Information provided by:
Sahlgrenska University Hospital, Sweden
ClinicalTrials.gov Identifier:
NCT01029808
First received: December 9, 2009
Last updated: July 19, 2011
Last verified: July 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To collect and analyze data on female carriers of severe and moderate hemophilia A and B.
| Condition |
|---|
|
Hemophilia |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Cross-Sectional |
| Official Title: | Bleeding Symptoms of Carriers of Hemophilia A and B |
Resource links provided by NLM:
Genetics Home Reference related topics:
hemophilia
MedlinePlus related topics:
Hemophilia
U.S. FDA Resources
Further study details as provided by Sahlgrenska University Hospital, Sweden:
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Carriers of severe and moderate hemophilia A and B
Criteria
Inclusion Criteria:
- Female carriers of hemophilia A and B.
Exclusion Criteria:
- Pregnancy.
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Anna Olsson/MD, Department of hematology and coagulation, Sahlgrenska university hopsital |
| ClinicalTrials.gov Identifier: | NCT01029808 History of Changes |
| Other Study ID Numbers: | VGAO002 |
| Study First Received: | December 9, 2009 |
| Last Updated: | July 19, 2011 |
| Health Authority: | Sweden: Regional Ethical Review Board |
Keywords provided by Sahlgrenska University Hospital, Sweden:
|
carriers of hemophilia |
Additional relevant MeSH terms:
|
Hemophilia A Hemorrhage Blood Coagulation Disorders, Inherited Blood Coagulation Disorders Hematologic Diseases Coagulation Protein Disorders Hemorrhagic Disorders |
Genetic Diseases, Inborn Pathologic Processes Factor VIII Coagulants Hematologic Agents Therapeutic Uses Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 23, 2013